Nuzenio

Formulation Development

Formulation Development news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Behind Every Shark Tank Food Pitch: The Formulation Lab You've Never Heard Of - Business StandardBusiness Standard · Thu, 06 Aug 2026 11:34:54 GMTKorea Eases OTC Drug Rules to Ease Vitamin Dual-Formulation Development - Seoul Economic DailySeoul Economic Daily · Thu, 06 Aug 2026 06:21:54 GMTArgent’s CannEpil expands into veterinary market - The AustralianThe Australian · Thu, 06 Aug 2026 05:10:00 GMTAltasciences Completes Expansion of Research and Development Laboratory in Harleysville, Pennsylvania - Via RitzauVia Ritzau · Tue, 04 Aug 2026 12:00:00 GMTCelonic and Leukocare to help clients with complex biologics and advanced drug product profiles - Manufacturing ChemistManufacturing Chemist · Wed, 29 Jul 2026 11:00:32 GMTGalmed Announces Breakthrough Development of Dispersible Film Delivery (ODF), Brain Penetrating formulation of its SCD1 inhibitor Aramchol for Parkinson's Disease, Targeting $6 Billion Market - PR NewswirePR Newswire · Tue, 28 Jul 2026 11:00:00 GMT

Timeline

Thu, 06 Aug 2026 11:34:54 GMTBehind Every Shark Tank Food Pitch: The Formulation Lab You've Never Heard Of - Business Standard
Thu, 06 Aug 2026 06:21:54 GMTKorea Eases OTC Drug Rules to Ease Vitamin Dual-Formulation Development - Seoul Economic Daily
Thu, 06 Aug 2026 05:10:00 GMTArgent’s CannEpil expands into veterinary market - The Australian
Tue, 04 Aug 2026 12:00:00 GMTAltasciences Completes Expansion of Research and Development Laboratory in Harleysville, Pennsylvania - Via Ritzau
Wed, 29 Jul 2026 11:00:32 GMTCelonic and Leukocare to help clients with complex biologics and advanced drug product profiles - Manufacturing Chemist
Tue, 28 Jul 2026 11:00:00 GMTGalmed Announces Breakthrough Development of Dispersible Film Delivery (ODF), Brain Penetrating formulation of its SCD1 inhibitor Aramchol for Parkinson's Disease, Targeting $6 Billion Market - PR Newswire

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Formulation Development.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.